Lead researcher Sam Berkovic, Director of the Epilepsy Research Centre at the University of Melbourne and Melbourne's Austin Hospital, said, as well as providing a pathway to treating epilepsy the research provides answers to patients and families who previously had little or no idea where epilepsy had come from, the AAP news agency reported.
"Parents often have a belief that they've done something wrong that caused this disease," Berkovic said.
"Not knowing why has been one of the most frustrating things. We've never really had the answer. Now we do. This also stops the need for further searching and refines the treatments," he said.
By using the latest genetic techniques to sequence and analyse DNA of 4,000 epilepsy patients and their relatives, the study known called Epi4Ks shared DNA sequences and patient information among dozens of research institutions.
Also Read
The researchers compared the exomes, or the complete sets of genes, of 264 children with the sequences of their parents who do not have epilepsy.
The study's other joint leader Dr David Goldstein, the Director of the Human Genome Variation Centre at Duke University Medical Centre in the US, said his team's work identified an unusually large number of disease-causing mutations and provided a wealth of new information.
"We are now headed toward a future where we can find out why people have this disease and tailor the treatment of it. It establishes a clear path to the genetic explanation of epilepsy," Dr Goldstein said.